MoonLake Immunotherapeutics
Price & Volume
Stats
See more52W Range | $5.95-$62.75 |
Market Cap | $753.1M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.33 |
News
See moreYahoo Finance • 2 days ago
ROSEN, NATIONAL TRIAL COUNSEL, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – MLTX
Yahoo Finance • 2 days ago
MLTX INVESTOR ALERT: MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
About
CEO | Dr. Jorge Santos da Silva Ph.D. |
Address | Dorfstrasse 29, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 100 |
